Kwang Pil Ko
Seoul National University · Medicine
About the Lab
Professor Kwang Pil Ko's research lab specializes in clinical and population-based studies focusing on chronic disease management, particularly hypertension and type 2 diabetes mellitus. The lab investigates the effectiveness of community-based health programs, patient adherence to treatment, and the impact of preventive interventions such as education and mandatory testing. It also explores the interplay between metabolic conditions, such as obesity and sarcopenia, and related comorbidities like peptic ulcer disease. Additionally, the lab examines clinical practices in surgical care, including prophylactic antibiotic use and surgical site infection rates, aiming to improve patient outcomes through evidence-based protocols.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15The coronavirus disease 2019 (COVID-19) pandemic is an emerging threat worldwide. It remains unclear how comorbidities affect the risk of infection and severity of COVID-19. Methods: This is a nationwide retrospective case-control study of 219,961 individuals, aged 18 years or older, whose medical costs for COVID-19 testing were claimed until May 15, 2020. COVID-19 diagnosis and infection severity were identified from reimbursement data using diagnosis codes and on the basis of respiratory suppo
Isoflavones are phytoestrogens and natural plant compounds which are similar to 17-β-estradiol in chemical structure. It is known that they can act as estrogen agonists or antagonists, depending on endocrine estrogenic levels, but actions of isoflavones are rather complex due to large number of variables such as chemical structures and mechanisms. Some hypotheses on biological mechanisms have not satisfactorily been confirmed to date and human epidemiological and experimental studies have been r
A subadditive effect of hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is possible because superinfection of one virus tends to inhibit infection of the other virus. However, studies have reported inconsistent findings, and two meta-analyses of studies from various countries (1998) and China (2005) reported a supraadditive effect for hepatocellular carcinoma (HCC) risk. Thus, we reevaluate HBV/HCV monoinfection and coinfection. Of 411 reports, we included 59 studies that assesse
These results suggest a beneficial effect of high soybean product intake for gastric cancer risk.
Frequent soybean/tofu intake was associated with lower risk of gastric cancer.
In the Asia-Pacific region, gastric, colorectal, and hepatocellular (liver) cancer show substantial regional variation in incidence consistent with the presence of important environmental factors. For gastric cancer, global incidence is concentrated in Asia with substantially higher rates in East Asia than in South-East Asia and Australia. The differences in incidence rates for gastric cancer in the Asia-Pacific region may be due, in part, to differences in the prevalence of Helicobacter pylori
Gastric cancer has been consistently decreasing worldwide, whereas cardia gastric cancer is on the rise. This indicates that the exposure rates to epidemiological causes are changing. In this study, we aim to review the risk factors for gastric cancer with respect to cardia and non-cardia types. One of the most significant risk factors for gastric cancer is <i>Helicobacter pylori</i> infection. <i>H. pylori</i> infection is known as a risk factor for non-cardia gastric cancer, and there have bee
Tobacco smoke is an established carcinogen, but the association between tobacco smoking and cancer risk in BRCA mutation carriers is not clear. The aim of this study was to evaluate prospectively the association between tobacco smoking and cancer incidence in a cohort of BRCA1 and BRCA2 mutation carriers. The study population consisted of unaffected BRCA mutation carriers. Information on lifestyle including smoking histories, reproductive factors, and past medical histories was obtained through
Both overall obesity and central obesity predicted risk of developing multiple metabolic risk factors, and WHR appeared to be a better discriminator than BMI. To prevent development of metabolic diseases among Koreans, it might be useful to lower the cutoff for abdominal obesity, as defined by WC.
Research Areas
Dive deeper into Kwang Pil Ko's research on Nubint
Open this lab's papers in the app to read with AI, summarize, and cite in your writing.